Home/Evecxia Therapeutics/Jacob Jacobsen, PhD

JJ

Jacob Jacobsen, PhD

Co-Founder, Chief Executive Officer

Evecxia Therapeutics

Therapeutic Areas

Psychiatry Mental Health Major Depressive Disorder

Evecxia Therapeutics Pipeline

Drug	Indication	Phase
EVX-101 (5-HTP-based therapy)	Major Depressive Disorder (MDD) - Adjunctive Treatment	Pre-clinical

Leadership Team at Evecxia Therapeutics

Jennifer Hart, MS

Executive Director, Operations

View full Evecxia Therapeutics profile